Are there any promising new technologies on the horizon for managing glaucoma?

Bimatoprost has been used for many years for treating glaucoma. (abnormal eye pressures) prior to the arrival of Latisse to the market to treat eyelash growth. Bimatoprost has a rejuvenating effects on the hair follicles. This was first noticed when the eye drops caused a lengthening and thickening of the eyelashes. Dec 5, 2019 ... Latisse is an FDA-approved prescription drug (bimatoprost ophthalmic solution, 0.03%), to help lengthen, thicken and darken eyelashes. Jun 27, 2021 ... What side effects can Bimatoprost Eye Drop cause? ... Iris darkening may occur due to gradual increase in the amount of brown pigment and result ... Nov 28, 2022 ... At full retail price, it costs $165 for a single three milliliter (mL) vial of 0.03% bimatoprost ophthalmic solution. This should be enough medicine to last 30 ... Sep 11, 2024 ... Bimatoprost has gained widespread recognition for its ability to promote eyelash growth, making it a popular choice for enhancing facial appearance. Aug 5, 2024 ... The funded brand of Bimatoprost 0.03% eye drops is changing from Bimatoprost (Multichem) to Lumigan. This change began on 1 August 2024. Bimatoprost (available through a brand called Lumigan) is administered to treat high level of intraocular pressure (ie, IOP). Bimatoprost-containing eye drops are used to treat Glaucoma. High intraocular pressure damages the optic nerves and is the root cause. Indicated for reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.